Kathryn E Lancaster1, Cynthia Kwok2, Anne Rinaldi2, Josaphat Byamugisha3, Tulani Magwali4, Prisca Nyamapfeni4, Robert A Salata5, Charles S Morrison2. 1. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: klancaster@unc.edu. 2. FHI 360, Durham, NC, USA. 3. Faculty of Medicine, Makerere University, Kampala, Uganda. 4. Department of Obstetrics and Gynecology, University of Zimbabwe, Harare, Zimbabwe. 5. Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Abstract
OBJECTIVE: To describe pregnancy outcomes among HIV-infected women and examine factors associated with live birth among those receiving and not receiving combination antiretroviral therapy (cART). METHODS: The present analysis included women with HIV from Uganda and Zimbabwe who participated in a prospective cohort study during 2001-2009. Incident pregnancies and pregnancy outcomes were recorded quarterly. The Kaplan-Meier method was used to estimate incident pregnancy probabilities; factors associated with live birth were evaluated by Poisson regression with generalized estimating equations. RESULTS: Among 306 HIV-infected women, there were 160 incident pregnancies (10.1 per 100 women-years). The pregnancy rate was higher among cART-naïve women than among those receiving cART (10.7 vs 5.5 per 100 women-years; P=0.047), and it was higher in Uganda than in Zimbabwe (14.4 vs 7.7 per 100 women-years; P<0.001). Significant associations were noted between a live birth and prenatal care (relative risk 3.9; 95% confidence interval 2.2-6.9) and illness during pregnancy (relative risk 0.8; 95% confidence interval 0.7-1.0). CONCLUSION: Women not receiving cART have higher pregnancy rates than do those receiving cART, but cART use might not affect the risk of adverse pregnancy outcomes. Timely prenatal care and monitoring of illnesses during pregnancy should be incorporated into treatment services for HIV-infected women.
OBJECTIVE: To describe pregnancy outcomes among HIV-infectedwomen and examine factors associated with live birth among those receiving and not receiving combination antiretroviral therapy (cART). METHODS: The present analysis included women with HIV from Uganda and Zimbabwe who participated in a prospective cohort study during 2001-2009. Incident pregnancies and pregnancy outcomes were recorded quarterly. The Kaplan-Meier method was used to estimate incident pregnancy probabilities; factors associated with live birth were evaluated by Poisson regression with generalized estimating equations. RESULTS: Among 306 HIV-infectedwomen, there were 160 incident pregnancies (10.1 per 100 women-years). The pregnancy rate was higher among cART-naïve women than among those receiving cART (10.7 vs 5.5 per 100 women-years; P=0.047), and it was higher in Uganda than in Zimbabwe (14.4 vs 7.7 per 100 women-years; P<0.001). Significant associations were noted between a live birth and prenatal care (relative risk 3.9; 95% confidence interval 2.2-6.9) and illness during pregnancy (relative risk 0.8; 95% confidence interval 0.7-1.0). CONCLUSION:Women not receiving cART have higher pregnancy rates than do those receiving cART, but cART use might not affect the risk of adverse pregnancy outcomes. Timely prenatal care and monitoring of illnesses during pregnancy should be incorporated into treatment services for HIV-infectedwomen.
Authors: Charles S Morrison; Barbra A Richardson; Francis Mmiro; Tsungai Chipato; David D Celentano; Joanne Luoto; Roy Mugerwa; Nancy Padian; Sungwal Rugpao; Joelle M Brown; Peter Cornelisse; Robert A Salata Journal: AIDS Date: 2007-01-02 Impact factor: 4.177
Authors: Irving F Hoffman; Francis E A Martinson; Kimberly A Powers; David A Chilongozi; Emmie D Msiska; Emma I Kachipapa; Chimwemwe D Mphande; Mina C Hosseinipour; Harriet C Chanza; Rob Stephenson; Amy O Tsui Journal: J Acquir Immune Defic Syndr Date: 2008-04-01 Impact factor: 3.731
Authors: Amanda Ross; Lieve Van der Paal; Rosemary Lubega; Billy N Mayanja; Leigh Anne Shafer; Jimmy Whitworth Journal: AIDS Date: 2004-03-26 Impact factor: 4.177
Authors: Mary V Kinney; Kate J Kerber; Robert E Black; Barney Cohen; Francis Nkrumah; Hoosen Coovadia; Paul Michael Nampala; Joy E Lawn; Henrik Axelson; Anne-Marie Bergh; Mickey Chopra; Roseanne Diab; Ingrid Friberg; Oladoyin Odubanjo; Neff Walker; Eva Weissman Journal: PLoS Med Date: 2010-06-21 Impact factor: 11.069
Authors: Fredrick E Makumbi; Gertrude Nakigozi; Steven J Reynolds; Anthony Ndyanabo; Tom Lutalo; David Serwada; Fred Nalugoda; Maria Wawer; Ron Gray Journal: AIDS Res Treat Date: 2011-01-19
Authors: Charles S Morrison; Raina Fichorova; Pai-Lien Chen; Cynthia Kwok; Jennifer Deese; Hidemi Yamamoto; Sharon Anderson; Tsungai Chipato; Robert Salata; Gustavo F Doncel Journal: AIDS Res Hum Retroviruses Date: 2018-09-05 Impact factor: 2.205
Authors: Elizabeth Wastnedge; Donald Waters; Sarah R Murray; Brian McGowan; Effie Chipeta; Alinane Linda Nyondo-Mipando; Luis Gadama; Gladys Gadama; Martha Masamba; Monica Malata; Frank Taulo; Queen Dube; Kondwani Kawaza; Patricia Munthali Khomani; Sonia Whyte; Mia Crampin; Bridget Freyne; Jane E Norman; Rebecca M Reynolds Journal: J Glob Health Date: 2021-12-30 Impact factor: 4.413